Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 AUD | -3.45% |
|
+12.00% | +21.74% |
06-13 | Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement | MT |
06-05 | Arovella Therapeutics Completes Process Development for ALA-101 Manufacturing; Shares Jump 9% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.74% | 101M | |
+23.13% | 46.93B | |
+37.49% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Manufactures GMP-Grade Lentiviral Vector for Cancer Therapy Product; Shares Climb 4%